Francois Nader

Type: Person
Name: Francois Nader
First reported 5 hours ago - Updated 2 hours ago - 1 reports

NPS Pharma will have to wait another three months for an FDA OK

NPS CEO Francois NaderThe FDA has postponed its final decision on an orphan drug from NPS Pharma ($NPSP), taking its time with the company's application and delaying the fate of a closely watched therapy.The agency has extended its review by three months, ... [Published FierceBiotech - 5 hours ago]
First reported Oct 22 2014 - Updated Oct 22 2014 - 1 reports

Introducing the FDA/CMS Summit for Biopharmaceutical Executives

Join us for the 10th Annual FDA-CMS Summit, for biopharmaceutical executives, December 11-12, 2014 in Washington, DC. Our keynote speakers and panels will take a deep dive into each of these topics, and more. You'll leave better able to make strategic ... [Published Future of BioPharma - Oct 22 2014]
First reported Oct 20 2014 - Updated Oct 20 2014 - 1 reports

Merrill Lynch’s 5 Destroyed Biotech Stocks With 100% or More Upside Potential

While Friday was a welcome relief for shell-shocked stock investors, much of the damage that has been inflicted since the start of the quarter is still weighing on some top biotech stocks. A new report from Merrill Lynch highlights five biotechs that ... [Published 24/7 Wall St - Oct 20 2014]
First reported Oct 14 2014 - Updated Oct 14 2014 - 1 reports

BioNJ’s 2nd Annual CEO Summit on October 20-21 Charts the Course for Success

The 2ndAnnual BioNJ CEO Summit , scheduled for October 20-21 at theBridgewater Marriott, will bring together some of the most influentialleaders in the life sciences industry to address the major opportunitiesand challenges facing the future of the sector ... [Published Reliance Trust - Oct 14 2014]
First reported Sep 22 2014 - Updated Sep 23 2014 - 1 reports

BioNJ Industry Study Looks Beyond Biotechnology Sector, Finding Contributions and Needs of Life Sciences Industry in New Jersey

Recognizing the continuing evolution of New Jersey’s life sciences industry, BioNJ today released a comprehensive report that documents the ongoing growth of the biotechnology sector in the State and combines and assesses the contributions of the entirety ... [Published Wall Street Select - Sep 22 2014]
First reported Sep 15 2014 - Updated Sep 16 2014 - 2 reports

NPS Pharma Hormone Drug Wins Shaky Endorsement From FDA Panel

09/15/14 - 09:32 AM EDTBEDMINSTER, NJ ( TheStreet ) -- NPS Pharmaceuticals ( NPSP ) shares are down 11% in early Monday trading following a rough outing for its hormone replacement therapy Natpara at an FDA advisory panel on Friday.Independent experts ... [Published TheStreet.com - Sep 15 2014]
First reported May 08 2014 - Updated May 08 2014 - 1 reports

NPS Pharma Blames Winter, Drug Stops for Weak First Quarter, Reduced Guidance

NPS Pharmaceuticals reported first-quarter net sales of Gattex totaling $17.9 million, a consensus miss which the company blames on bad winter weather and a rise in the number of patients discontinuing therapy. The slow start to the year means NPS Pharma ... [Published The Street Latest - May 08 2014]

More Content

All (13) | News (12) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
FDA Postpones Its Final Decision On Point Looko... [Published BioSpace - 2 hours ago]
NPS Pharma will have to wait another three mont... [Published FierceBiotech - 5 hours ago]
PDUFA Action Date for Natpara® BLA Extended Thr... [Published Investor's Business Daily - 21 hours ago]
PDUFA Action Date for Natpara® BLA Extended Thr... [Published Industrial Info Financials - 21 hours ago]
Introducing the FDA/CMS Summit for Biopharmaceu... [Published Future of BioPharma - Oct 22 2014]
NPS Pharmaceuticals Inc. (NPSP) Jumps 8.75% on ... [Published Equities.com - Oct 20 2014]
Merrill Lynch’s 5 Destroyed Biotech Stocks With... [Published 24/7 Wall St - Oct 20 2014]
BioNJ’s 2nd Annual CEO Summit on October 20-21 ... [Published Reliance Trust - Oct 14 2014]
BioNJ Industry Study Looks Beyond Biotechnology... [Published Wall Street Select - Sep 22 2014]
NPS Pharma Hormone Drug Wins Shaky Endorsement ... [Published TheStreet.com - Sep 15 2014]
NPS Pharma Hormone Drug Wins Shaky Endorsement ... [Published The Street Latest - Sep 15 2014]
NPS Pharma Blames Winter, Drug Stops for Weak F... [Published The Street Latest - May 08 2014]
NPS Pharma's hypoparathyroidism drug Natpara ge... [Published PharmaBiz - Jan 07 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Introducing the FDA/CMS Summit for Biopharmaceu... [Published Future of BioPharma - Oct 22 2014]
Join us for the 10th Annual FDA-CMS Summit, for biopharmaceutical executives, December 11-12, 2014 in Washington, DC. Our keynote speakers and panels will take a deep dive into each of these topics, and more. You'll leave better able to make strategic ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.